Loading provider…
Loading provider…
Gastroenterology Physician in Beverly Hills, CA
NPI: 1336102524Primary Practice Location
Spalding Triangle Surgery Center
120 South Spalding Drive, Beverly Hills, CA
Primary Employer
Cedars-Sinai Medical Center
cedars-sinai.org
HQ Phone
Get M.D. Gil's Phone Numberphone_androidMobile
Get M.D. Gil's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
2002 - 2026
CA State Medical License

American Board of Internal Medicine
Gastroenterology
UCLA David Geffen School of Medicine/UCLA Medical Center
Fellowship • Gastroenterology
2003 - 2006
Cedars-Sinai Medical Center
Residency • Internal Medicine
2000 - 2003
Albert Einstein College of Medicine
einsteinmed.edu
Medical School
Until 2000
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 58 | 69 |
| 2 | 45380Biopsy of the large bowel using an endoscope (colonoscopy) | 34 | 36 |
| 3 | 43239Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | 15 | 16 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 12 | 12 |
Authors: Vivek Rudrapatna, Berkeley Limketkai, Nimisha Parekh, Jenny Sauk, Sunhee Park, Dermot Mcgovern, Gaurav Syal, Uma Mahadevan, Sonia Ramamoorthy, Phillip Fleshner, Parambir Dulai, Vivek Rudrapatna, Samuel Eisenstein, William Sandborn, Nghia Nguyen, Christina Ha
Journal: Clin Gastroenterol Hepatol
Publication Date: 2022-05-27
Antibiotics for Treatment of Clostridium difficile Infection in Hospitalized Patients with Inflammatory Bowel Disease.
Authors: Eric Vasiliauskas, Andrew Ippoliti
Publication Date: 2014-06-11
Identifying and Predicting the Goals and Concerns Prioritised by Individuals with Inflammatory Bowel Disease.
Authors: Corey Siegel, Brittany Ricci, Chung Sang Tse, Samir Shah
Publication Date: 2021-08-05
Lead Sponsor: Cedars-Sinai Medical Center
Intervention / Treatment: DRUG: Tofacitinib 10 mg
Lead Sponsor: Cedars-Sinai Medical Center
Intervention / Treatment: BEHAVIORAL: Proactive Analgesic Inpatient Narcotic-Sparing
Lead Sponsor: Cedars-Sinai Medical Center
Intervention / Treatment: DIETARY_SUPPLEMENT: Placebo, DIETARY_SUPPLEMENT: 5000 IU D3, DIETARY_SUPPLEMENT: 1000 IU D3